Status:
WITHDRAWN
Lung Clearance Index and Lung Allograft Dysfunction
Lead Sponsor:
University of Zurich
Conditions:
Lung Transplantation
Chronic Lung Allograft Dysfunction
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this project is to evaluate the ability of the lung clearance index (LCI) to detect early chronic lung allograft failure (CLAD) in adult lung transplant recipients over a period of 3 years.
Detailed Description
This single center study consists of three parts: 1. Characterisation of the Zurich lung transplant cohort regarding CLAD status and pulmonary function impairment (cross-sectional, study part I) 2. E...
Eligibility Criteria
Inclusion
- Male and female lung transplant recipients
- Written informed consent by the participant after information about the research project
Exclusion
- Any contraindication to perform pulmonary function tests (e.g., persistent pneumothorax)
- Acute airway infection
- Chronic infection due to Burkholderia spp and nontuberculosis mykobacteria NTM
Key Trial Info
Start Date :
March 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03850002
Start Date
March 1 2019
End Date
September 30 2023
Last Update
July 25 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.